NewsBenzingaOcugen Executes Licensing Agreement With Roots Pharma And Its Strategic Partner Al-Dhow International For Exclusive Rights To OCU400 For Treatment Of Retinitis Pigmentosa In Middle East And North Africa Region Ocugen Executes Licensing Agreement With Roots Pharma And Its Strategic Partner Al-Dhow International For Exclusive Rights To OCU400 For Treatment Of Retinitis Pigmentosa In Middle East And North Africa Region Benzinga 2026.10.14 10:32 (GMT+0) Open on Benzinga Other news BTIG Reiterates Buy on Nexxen International, Maintains $13 Price Target Morgan Stanley Maintains Equal-Weight on Xcel Energy, Raises Price Target to $85 Morgan Stanley Maintains Equal-Weight on Western Midstream, Lowers Price Target to $52 Morgan Stanley Maintains Overweight on Vistra, Lowers Price Target to $226 Alaska Air Gr Q3 2026 Earnings Call Transcript If You Invested $1000 In Cogent Biosciences Stock 5 Years Ago, You Would Have This Much Today
